Dual inhibition of EGFR and PI3K with a single drug

Whitehead, C. E. et al. Nat. Cancer https://doi.org/10.1038/s43018-024-00781-6 (2024).

Johnson, M., Garassino, M. C., Mok, T. & Mitsudomi, T. Lung Cancer 170, 41–51 (2022).

Article  CAS  PubMed  Google Scholar 

Chhouri, H., Alexandre, D. & Grumolato, L. Cancers (Basel) 15, 504 (2023).

Article  CAS  PubMed  Google Scholar 

Rehmani, H. S. & Issaeva, N. Ann. Transl. Med. 8, 813 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Xie, Y.-H., Chen, Y.-X. & Fang, J.-Y. Signal Trans. Targeted Ther. 5, 22 (2020).

Article  CAS  Google Scholar 

Diniz, C. H. D. P., Henrique, T., Stefanini, A. C. B., De Castro, T. B. & Tajara, E. H. Oncol. Rep. 51, 80 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Tankova, T. et al. Cancers 14, 1598 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chauhan, A. F. & Cheson, B. D. Cancer Manag. Res. 13, 677–692 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Chandarlapaty, S. et al. Cancer Cell 19, 58–71 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klinghammer, K. et al. Oncotarget 11, 3688–3697 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Elkabets, M. et al. Cancer Cell 27, 533–546 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Razak, A. R. A. et al. Target. Oncol. 18, 853–868 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Marret, G. et al. Invest. New Drugs 39, 1641–1648 (2021).

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif